Compare ANSC & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANSC | AVIR |
|---|---|---|
| Founded | 2021 | 2012 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.1M | 450.9M |
| IPO Year | N/A | 2020 |
| Metric | ANSC | AVIR |
|---|---|---|
| Price | $11.30 | $5.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 44.4K | ★ 250.9K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $55.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.70 | $2.46 |
| 52 Week High | $11.34 | $6.45 |
| Indicator | ANSC | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 54.13 |
| Support Level | $11.13 | $3.28 |
| Resistance Level | N/A | $6.37 |
| Average True Range (ATR) | 0.03 | 0.23 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 60.00 | 69.23 |
Agriculture & Natural Solutions Acquisition Corp is a blank check company.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.